Mr. Steven McAuley reports

EMPOWER CLINICS PROVIDES CORPORATE UPDATE

Empower Clinics Inc. has provided various corporate updates.

May 6, 2022, filing disclosure update

As a result of a review by the British Columbia Securities Commission, the company is issuing the following press release to clarify its disclosure. The company advises that the May 6, 2022, restated unaudited condensed interim consolidated financial statements and related management's discussion and analysis for the three and six months ended Sept. 30, 2021, were duly authorized prior to filing, however there was an incorrect director name included on the filed documents.

In consultation with the board of directors and accounting services the company has implemented measures to ensure this type of oversight does not happen in the future.

The company also announces that it entered into debt settlement agreements with creditors on May 15, 2023, for the settlement of debt in the aggregate amount of $67,531.40, which was settled through the issuance of an aggregate of 4,502,093 common shares in the capital of the company at a deemed issue price of 1.5 cents per share considered.

About Empower Clinics Inc.

Empower is an integrated health care company with multidisciplinary clinics, a Canadian medical device company and has launched its first clinical research site, becoming a site management organization (SMO) in Dallas, Tex. Empower is a leader in integrated health care and research solutions and is reshaping the model for patient-first wellness

We seek Safe Harbor.